proqrtherapeutics(

ProQR Therapeutics(PRQR)：

ProQR Therapeutics(PRQR) RW Registration Withdrawal Request Accession Number: 0001104659-23-038375  Act: NE  Size: 7 KB 网页链接

ProQR Therapeutics(PRQR)：

ProQR Therapeutics(PRQR) SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000315066-23-002016  Act: 34  Size: 7 KB 网页链接

ProQR Therapeutics(PRQR)：

ProQR Therapeutics(PRQR) 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-23-031166  Act: 34  Size: 10 KB 网页链接

ProQR Therapeutics(PRQR)：

ProQR Therapeutics(PRQR) SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-23-001358  Act: 34  Size: 101 KB 网页链接

ProQR Therapeutics(PRQR)：

ProQR Therapeutics(PRQR) SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000769993-23-000104  Act: 34  Size: 23 KB 网页链接

ProQR Therapeutics(PRQR)：

ProQR Therapeutics(PRQR) 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001558370-23-004917  Act: 34  Size: 14 MB 网页链接

ProQR Therapeutics(PRQR)：

ProQR Therapeutics(PRQR) F-3 Registration statement by foreign private issuers Accession Number: 0001104659-23-038374  Act: 33  Size: 930 KB 网页链接

全球新药浪潮：

ProQR Announces Initial Pipeline Targets and Highlights Axiomer® RNA Editing Platform Technology at R&D EventProQR Therapeutics(PRQR)

ProQR Therapeutics(PRQR)：

ProQR Therapeutics(PRQR) 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-23-037998  Act: 34  Size: 43 KB 网页链接

ProQR Therapeutics(PRQR)：

ProQR Therapeutics(PRQR) SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-23-017651  Act: 34  Size: 94 KB 网页链接

ProQR Therapeutics(PRQR)：

ProQR Therapeutics(PRQR) SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-23-001734  Act: 34  Size: 61 KB 网页链接